Financial Toxicity
14
6
6
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (14)
SAFE.AI: Developing and Testing an AI-based Hybrid Chatbot for Financial Empowerment in Rural Cancer Care
Exploring Physical and Psychological Needs and Quality of Life in Patients With Advanced Cancer Receiving Immunotherapy
Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas
Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation
Financial Toxicity and Quality of Life in Hospitalized Cancer Patients: A Multicenter Study
Proactive Costs of Care Study
A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost Discussions
DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer
Efficacy of Structured SOcial COnsultation and Support in Reducing the FINancial Burden of Radiotherapy
Financial Navigation Program for Improving Financial Toxicity Among Breast Cancer in China
Pilot Study of Financial Navigation Program for Improving Financial Toxicity Among Breast Cancer in China
Feasibility and Utilization of an Application-based Question Prompt List
A Survey of Financial Toxicity in Rural Cancer Patients
A Longitudinal Study of the Trajectory of Financial Toxicity and Its Relationship With Symptom Burden in Breast Cancer Patients